NM_007078.3:c.2016C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_007078.3(LDB3):​c.2016C>T​(p.Cys672Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00448 in 1,613,954 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 26 hom. )

Consequence

LDB3
NM_007078.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.911

Publications

2 publications found
Variant links:
Genes affected
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
LDB3 Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 4
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial dilated cardiomyopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-86726174-C-T is Benign according to our data. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86726174-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 45538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.911 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00274 (417/152268) while in subpopulation NFE AF = 0.00501 (341/68012). AF 95% confidence interval is 0.00457. There are 1 homozygotes in GnomAd4. There are 198 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 26 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDB3NM_007078.3 linkc.2016C>T p.Cys672Cys synonymous_variant Exon 13 of 14 ENST00000361373.9 NP_009009.1 O75112-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDB3ENST00000361373.9 linkc.2016C>T p.Cys672Cys synonymous_variant Exon 13 of 14 1 NM_007078.3 ENSP00000355296.3 O75112-1

Frequencies

GnomAD3 genomes
AF:
0.00274
AC:
417
AN:
152150
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00501
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00248
AC:
623
AN:
251462
AF XY:
0.00224
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00488
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00466
AC:
6818
AN:
1461686
Hom.:
26
Cov.:
31
AF XY:
0.00451
AC XY:
3279
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33472
American (AMR)
AF:
0.000917
AC:
41
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00168
AC:
44
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86250
European-Finnish (FIN)
AF:
0.000318
AC:
17
AN:
53418
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5668
European-Non Finnish (NFE)
AF:
0.00585
AC:
6505
AN:
1111938
Other (OTH)
AF:
0.00306
AC:
185
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
349
699
1048
1398
1747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00274
AC:
417
AN:
152268
Hom.:
1
Cov.:
32
AF XY:
0.00266
AC XY:
198
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000986
AC:
41
AN:
41562
American (AMR)
AF:
0.00163
AC:
25
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00501
AC:
341
AN:
68012
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00405
Hom.:
1
Bravo
AF:
0.00262
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00338
EpiControl
AF:
0.00462

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 09, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LDB3: BP4, BP7, BS2 -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 15, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:5
Jul 23, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cys672Cys in exon 15 of the LDB3 gene: This variant does not not alter an amino acid residue and is not located near a splice junction. Although some base chang es that do not result in amino acid changes can be associated with disease, this variant occurs in ~1% of the general population; rs45578640) and is therefore m ost likely benign. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 29, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Myofibrillar myopathy 4 Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LDB3-related disorder Benign:1
Aug 08, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Cardiovascular phenotype Benign:1
May 04, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.56
DANN
Benign
0.57
PhyloP100
-0.91
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45578640; hg19: chr10-88485931; API